Therigy, LLC recently added OncoSource Rx to its network of high performing specialty pharmacies. OncoSource Rx will utilize TherigySTM — a HIPAA compliant specialty therapy management Web application-to provide consistent care to their patients on oral oncology medications. TherigySTM consists of preconfigured Best Practice assessments and interventions designed to maximize compliance and adherence, improve outcomes through an accurate and reliable data collection and report data to all stakeholders.
"Therigy is looking forward to working with leading oncology pharmacies, such as OncoSource Rx, in providing the highest level of service to their patients," comments Joseph Morse, President for Therigy. "OncoSource Rx is a leader in the Specialty Pharmacy market and we believe TherigySTM will enable them to streamline their patient care process and enhance the high-touch patient model that has made OncoSource Rx successful."
"OncoSource Rx is a best-in-class specialty pharmacy dedicated to providing innovative services that make healthcare safer and more productive," said Recie Bomar, Vice President of OncoSource Rx. "Therigy is making a remarkable impact on the future of specialty therapy management with TherigySTM and we are proud to be a part of that future. Implementing TherigySTM into our daily operations will allow us to focus on delivering the best possible treatments, consistent care, and improve patient outcomes."